Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...
Men’s health issues, such as prostate cancer and mental health concerns, include conditions like metabolic syndrome (MetS), which can greatly affect men’s quality of life and vitality. By 2040, ...